For instance, Yuan et al. recently reported that clustered CNAs (copy number gains) on chromosome 7p were associated with poorer survival and less favorable response to EGFR tyrosine kinase inhibitors in EGFR-mutated adenocarcinomas specifically [17]. The gene discussed is EGFR; the disease is adenocarcinoma.